A
TRUSTED WELLNESS COMPANY

Retail Brand Highlights

Understanding the need to offer robust and convenient Coronavirus testing we have increased our number of clinics.

Record sales in December.

Launched Goodbody Store housing the Goodbody Botanicals and Goodbody Wellness brands.

Developed and launched a premium CBD with Vitamin D product range under the Goodbody Wellness brand.

A Trusted Wellness Company

“With European extraction, UK manufacturing, lab testing, established brands and distribution, our CBD therapeutics division underpins Sativa. Our COVID travel testing and blood testing for vaccine validation provides significant current and future revenues”.

Geremy Thomas

Founder of Sativa Wellness Group Inc.

Cultivation & Extraction
Proprietary extraction techniques that set the standard for quality.

MORE
Quality Control
The UK’s premier testing facility for CBD and hemp-based products.

MORE
Manufacturing
State of the art product development and white labeling services.

MORE
Brands
A portfolio of unique brands tailored to key consumer demographics.

MORE
Sales Channels
Retail and wholesale channels designed for today's fast evolving consumer expectations.

MORE

Latest Updates

ANNOUNCEMENT: Sativa Wellness Groups Laboratory achieves ISO17025 Accreditation

Sativa Wellness Group is pleased to announce that the Company’s subsidiary PhytoVista Laboratories has been granted accreditation to ISO/IEC 17025:2017, General requirements for the competence of testing and calibration laboratories.

Accreditation for the testing of cannabinoids has been granted by United Kingdom Accreditation Service (UKAS), the UK governments appointed National Accreditation Body. The accreditation process determines the technical competence and integrity of organisations such as those offering testing services.

ANNOUNCEMENT: PDMR Director Disclosure

Sativa Wellness Group announces that as part of the recent closure of the first tranche of its non-brokered private placement of units of the Company (each, a “Unit”) previously announced on April 9, 2021 (the “Placement”) Clive Standish, one of the board of directors took part.

ANNOUNCEMENT: Closing of First Tranche of $4.5 Million Private Placement

Sativa Wellness Group is pleased to announce that it has closed the first tranche of its non-brokered private placement of units of the Company (each, a “Unit”) previously announced on February 24, 2021 (the “Offering”). In this closing, the Company issued an aggregate of 45,888,730 Units at a price of C$0.07875 per Unit for aggregate gross proceeds of C$3,613,737.49.